BIOBANK Renal Transplantation University Hospitals Leuven

May 6, 2024 updated by: Prof Dr Maarten Naesens, Universitaire Ziekenhuizen KU Leuven

Biobank Renal Transplantation University Hospitals Leuven

This study aims to maintain a prospective biobank of human samples obtained from donors and recipients of renal allografts, including biopsy tissue, peripheral blood samples and urine samples.

Study Overview

Status

Recruiting

Conditions

Detailed Description

Clinical data and bio-specimens are prospectively collected and stored for undefined future translational research projects.

Study Type

Observational

Enrollment (Estimated)

5000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • BE
      • Leuven, BE, Belgium, 3000
        • Recruiting
        • Department of Nephrology and Renal Transplantation - University Hospitals Leuven
        • Contact:
        • Principal Investigator:
          • Maarten Naesens, MD, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

All donors and recipients of a kidney transplant at the University Hospitals Leuven

Description

Inclusion Criteria:

  • renal transplant recipients/donors

Exclusion Criteria:

  • none

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
renal allograft donors and recipients
All de novo renal allograft recipients transplanted at the University Hospitals Leuven

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Renal allograft survival
Time Frame: 50 years after transplantation
50 years after transplantation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Maarten Naesens, MD, PhD, Universitaire Ziekenhuizen KU Leuven

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2004

Primary Completion (Estimated)

December 1, 2099

Study Completion (Estimated)

December 1, 2099

Study Registration Dates

First Submitted

April 6, 2011

First Submitted That Met QC Criteria

April 6, 2011

First Posted (Estimated)

April 8, 2011

Study Record Updates

Last Update Posted (Actual)

May 8, 2024

Last Update Submitted That Met QC Criteria

May 6, 2024

Last Verified

May 1, 2024

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Kidney Failure

Subscribe